Primary hyperaldosteronism.

Area of Science:

• Endocrinology
• Internal Medicine
• Nephrology

Background:

• Primary hyperaldosteronism presents diagnostic challenges due to low incidence and varied pathophysiology.
• Serum potassium levels are a standard screening tool but have limitations.
• Accurate diagnosis is essential for determining appropriate treatment strategies.

Purpose of the Study:

• To outline the diagnostic challenges and methods for primary hyperaldosteronism.
• To detail the biochemical and localization procedures for subtype identification.
• To emphasize the importance of differentiating subtypes for surgical management.

Main Methods:

• Routine screening with serum potassium measurements.
• Confirmatory tests include plasma and urine aldosterone levels and plasma renin activity.
• Advanced biochemical profiling and imaging for subtype classification.

Main Results:

• Diagnosis confirmation requires demonstrating high, nonsuppressible aldosterone and low renin activity.
• Subtypes identified include aldosterone-producing adenomas, primary adrenal hyperplasia, and unilateral hyperplasia.
• Rare subtypes like glucocorticoid-suppressible hyperaldosteronism and adrenal carcinoma also require identification.

Conclusions:

• Accurate diagnosis and subtype differentiation of primary hyperaldosteronism are complex but vital.
• Sophisticated biochemical and localization techniques are necessary for surgical candidate selection.
• Ongoing research into pathophysiology will refine diagnostic and management strategies.